NGM Amends Collaboration with Merck to Focus Primarily on Advancing Novel Medicines for Retinal and Cardiovascular and Metabolic (CVM) Diseases

Paul Theisen
Patient Acquisition

Liz Kane
Impactful Strategy

Frank Burrell
Scientific Storytelling

Brenda Snow
Authentic Patient Voice

Stacey Gandler
Brand Nourishment

Bud Bilanich
Success Coach

David Linetsky
Point-of-Care Marketing

Daniel Sontupe
Market Access

Pat Purcell
Meeting Engagement

Suma Ramadas, PhD
Medical Affairs

Matt Turner
Patient Affordability

Matthew Durham
Omnidynamic Marketing

Amy Giles
Increasing Engagement

Joey Cohen
Medication Adherence